O Blin

Summary

Affiliation: Hopital Timone Enfant
Country: France

Publications

  1. ncbi Antipsychotic-associated weight gain and clinical outcome parameters
    O Blin
    Centre de Pharmacologie Clinique et d Evaluations Thérapeutiques, H pital de la Timone, Marseille, France
    J Clin Psychiatry 62:11-21. 2001
  2. ncbi [Perception of atypical antipsychotics' side effects through speech analysis of schizophrenic patients. TALK Study]
    S Bouloudnine
    pôle universitaire de psychiatrie, Hopital Ste Marguerite, Marseille, France
    Encephale 37:S143-50. 2011
  3. ncbi Weight gain profiles of new anti-psychotics: public health consequences
    S Tardieu
    , , Marseille, France
    Obes Rev 4:129-38. 2003
  4. ncbi Serotonin and human information processing: fluvoxamine can improve reaction time performance
    T Hasbroucq
    Centre de Recherches en Neurosciences Cognitives, Centre National de la Recherche Scientifique, Marseille, France
    Neurosci Lett 229:204-8. 1997
  5. ncbi Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients
    E Fakra
    CIC UPCET et Pharmacologie Clinique, Hopital de la Timone, UMR CNRS 6193 Institut des Neurosciences Cognitives de la Méditerranée, Marseille, France
    Psychopharmacology (Berl) 200:261-72. 2008
  6. ncbi A comparative review of new antipsychotics
    O Blin
    Centre de Pharmacologie Clinique et d Evaluations Thérapeutiques, Hopital de la Timone, Marseille, France
    Can J Psychiatry 44:235-44. 1999
  7. ncbi Neurobiology and clinical pharmacology of obsessive-compulsive disorder
    J Micallef
    Centre de Pharmacologie et d'Evaluations Therapeutiques and Department of Clinical Pharmacology, , , Timone University Hospital, Marseille, France
    Clin Neuropharmacol 24:191-207. 2001
  8. ncbi Schizophrenia and frontal cortex: where does it fail?
    P Salgado-Pineda
    Institut des Neurosciences Cognitives de la Méditerranée, Faculte de Medecine, Universite de la Mediterranee, UMR 6193 CNRS, Marseille, F 13385, France
    Schizophr Res 91:73-81. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Antipsychotic-associated weight gain and clinical outcome parameters
    O Blin
    Centre de Pharmacologie Clinique et d Evaluations Thérapeutiques, H pital de la Timone, Marseille, France
    J Clin Psychiatry 62:11-21. 2001
    ..This review examines whether antipsychotic-associated weight gain, when it occurs, is associated with clinical outcome parameters...
  2. ncbi [Perception of atypical antipsychotics' side effects through speech analysis of schizophrenic patients. TALK Study]
    S Bouloudnine
    pôle universitaire de psychiatrie, Hopital Ste Marguerite, Marseille, France
    Encephale 37:S143-50. 2011
    ..The objective of this study was to propose an alternative measure of patients'perception of atypical antipsychotics'side-effects on weight, as weight is a major concern reported by patients...
  3. ncbi Weight gain profiles of new anti-psychotics: public health consequences
    S Tardieu
    , , Marseille, France
    Obes Rev 4:129-38. 2003
    ..An understanding of these aspects is important for those who prescribe anti-psychotics in order to provide the patient the best therapeutic management...
  4. ncbi Serotonin and human information processing: fluvoxamine can improve reaction time performance
    T Hasbroucq
    Centre de Recherches en Neurosciences Cognitives, Centre National de la Recherche Scientifique, Marseille, France
    Neurosci Lett 229:204-8. 1997
    ..This result suggests that fluvoxamine spares the processing stages of stimulus preprocessing and response selection...
  5. ncbi Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients
    E Fakra
    CIC UPCET et Pharmacologie Clinique, Hopital de la Timone, UMR CNRS 6193 Institut des Neurosciences Cognitives de la Méditerranée, Marseille, France
    Psychopharmacology (Berl) 200:261-72. 2008
    ..However, studies have rarely controlled the nature of antipsychotic medication. Yet, the influence of these drugs on emotional response is uncertain and could vary depending on their pharmacological profile...
  6. ncbi A comparative review of new antipsychotics
    O Blin
    Centre de Pharmacologie Clinique et d Evaluations Thérapeutiques, Hopital de la Timone, Marseille, France
    Can J Psychiatry 44:235-44. 1999
    ..To review the preclinical and clinical properties of various established and putative antipsychotic medications, namely clozapine, risperidone, amisulpride, olanzapine, quetiapine, sertindole, and ziprasidone...
  7. ncbi Neurobiology and clinical pharmacology of obsessive-compulsive disorder
    J Micallef
    Centre de Pharmacologie et d'Evaluations Therapeutiques and Department of Clinical Pharmacology, , , Timone University Hospital, Marseille, France
    Clin Neuropharmacol 24:191-207. 2001
    ..Nondrug therapies are also important in OCD: behavioral therapy is frequently helpful and neurosurgery is sometimes helpful when other treatments fail...
  8. ncbi Schizophrenia and frontal cortex: where does it fail?
    P Salgado-Pineda
    Institut des Neurosciences Cognitives de la Méditerranée, Faculte de Medecine, Universite de la Mediterranee, UMR 6193 CNRS, Marseille, F 13385, France
    Schizophr Res 91:73-81. 2007
    ....